专题：国投白银LOF暴跌31.5%创纪录：估值调整惹争议 半月谈 0 36个朋友关注 u 6 +关注 395 来源 国际投行研究报告 网红基金单日暴跌超30%,"套利" 变"被套"谁之过? 原创 魏雨田 半月谈 2026年2月5日 12:11 北京 69 60人 半月谈评论 半月谈评论员 魏雨田 近日,国投瑞银基金公司旗下一只名为国投瑞 银白银LOF (上市型开放式基金)基金出现大 幅波动,单日净值暴跌31.5%,导致不少基民 损失惨重。这场风波远非"投资有风险"所能 概括,其本质是基金公司风险控制机制的缺 位,而信息披露环节的仓促处置,不仅损害了 投资者的合法积益,更为整个行业敲响了警 钟。 3364 ୧5 3 交易单详情 基金理财 46.91 份 | NA - I'A-13 | | --- | | 赎回确认金额小于实时到账金额,需补款18.24元 | | 请保持小金库余额充足,或进行汇款补款。 | | 查看补款方式 | 原创 魏雨田 半月谈 2026年2月5日 12:11 北京 69 60人 半月谈评论 | 产品名称: | 国投瑞银白银期货(LOF)A > | | --- | --- | | 赎回类型: ...

Group 1 - The core viewpoint is that several fund companies have collectively downgraded the valuation of the Hong Kong-listed company NuoHui Health, with some estimates dropping by over 90% from the pre-suspension price of 14.14 HKD to as low as 1.2 HKD [1] - On June 26, Bosera Fund announced a valuation of 3.33 HKD per share for NuoHui Health, while Great Wall Fund set its valuation at 1.2 HKD per share, indicating a significant reduction in perceived value [1] - NuoHui Health has been suspended since March 2024 due to allegations of financial fraud and audit concerns, leading to multiple valuation downgrades by various fund companies [1] Group 2 - In addition to NuoHui Health, the A-share market's ST Zitian also faced valuation downgrades, with Huaxia Fund reducing its valuation from 8.74 CNY to 2.5 CNY, reflecting a decline of over 70% [3] - The stringent valuation adjustments by fund companies for NuoHui Health and ST Zitian are attributed to financial uncertainties and operational risks, highlighting a trend of increasing risk management standards within the public fund industry [3] - Fund managers are reportedly becoming more selective about investment targets, with a stronger emphasis on company fundamentals, particularly avoiding ST stocks [3]